
Development of a clinical prediction model for benign and malignant pulmonary nodules with a CTRββ₯β50% utilizing artificial intelligence-driven radiomics analysis.
AI-driven model enhances diagnosis of pulmonary nodules. π€π Study shows promise in distinguishing benign from malignant cases.